Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 09, 2020 08:00 ET | Source: Vir Biotechnology, Inc.

Nature Publishes New Research from Vir Biotechnology Demonstrating the Capacity of Enhanced Monoclonal Antibodies to Induce Protective Adaptive Immunity to Viral Infection

Data demonstrate potential to enhance effector function of monoclonal antibodies and induce a protective T-cell or “vaccinal” response Therapeutic approach previously applied to treatment of oncologic...
October 06, 2020 08:18 ET | Source: Vir Biotechnology, Inc.

Vir Biotechnology and GSK announce global expansion to Phase 3 of COMET-ICE study evaluating VIR-7831 for the treatment of COVID-19

Independent Data Monitoring Committee recommended on September 30, 2020 that the study continue into Phase 3 based on a positive evaluation of safety and tolerability data from the Phase 2...
September 24, 2020 08:00 ET | Source: Vir Biotechnology, Inc.

Vir Biotechnology Publishes New Research Characterizing Antibody Response to SARS-CoV-2 in the Journal Cell

– Largest-to-date analysis of serum samples from nearly 650 SARS-CoV-2-infected patients – – High-resolution serology advances understanding of variations in natural antibody response to SARS-CoV-2...
September 09, 2020 16:10 ET | Source: Vir Biotechnology, Inc.

Vir Biotechnology to Present at Cantor Global Virtual Healthcare Conference

SAN FRANCISCO, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on treating and preventing serious infectious diseases, today...
September 08, 2020 16:01 ET | Source: Vir Biotechnology, Inc.

Vir Biotechnology to Present at H.C. Wainwright 22nd Annual Global Investment Conference

SAN FRANCISCO, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on treating and preventing serious infectious diseases, today...
September 01, 2020 16:01 ET | Source: Vir Biotechnology, Inc.

Vir Biotechnology Appoints Janet Napolitano to its Board of Directors

SAN FRANCISCO, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the appointment of Janet Napolitano to its board of directors. Napolitano brings a breadth of...
August 31, 2020 08:00 ET | Source: Vir Biotechnology, Inc.

Vir Biotechnology and GSK Start Phase 2/3 Study of COVID-19 Antibody Treatment

Phase 2/3 COMET-ICE study will investigate the safety and efficacy of antibody treatment in preventing hospitalization due to COVID-19 Potential for initial study results to be available before the...
August 20, 2020 08:00 ET | Source: Vir Biotechnology, Inc.

Vir Biotechnology Presents Data on VIR-2218 from Clinical Studies for the Treatment of Hepatitis B at the EASL Digital International Liver Congress™

SAN FRANCISCO, Aug. 20, 2020 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on treating and preventing serious infectious diseases, today...
August 11, 2020 16:01 ET | Source: Vir Biotechnology, Inc.

Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2020 Financial Results

SAN FRANCISCO, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on treating and preventing serious infectious diseases, today...
July 28, 2020 16:01 ET | Source: Vir Biotechnology, Inc.

Vir Biotechnology to Provide Corporate Update and Report Second Quarter 2020 Financial Results on August 11, 2020

SAN FRANCISCO, July 28, 2020 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on treating and preventing serious infectious diseases, today...